Eagle Pharmaceuticals, Inc.
EGRX · OTC
3/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3 | $36 | -$9 | $12 |
| Dep. & Amort. | $17 | $12 | $4 | $5 |
| Deferred Tax | $30 | -$8 | -$4 | -$2 |
| Stock-Based Comp. | $0 | $16 | $20 | $25 |
| Change in WC | $1 | -$16 | $10 | $1 |
| Other Non-Cash | -$14 | $11 | $8 | $9 |
| Operating Cash Flow | $31 | $51 | $28 | $49 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | -$74 | $0 | $0 |
| Inv. Purchases | $0 | -$13 | $0 | -$18 |
| Inv. Sales/Matur. | $0 | $74 | $0 | $0 |
| Other Inv. Act. | $0 | -$74 | -$5 | $0 |
| Investing Cash Flow | $0 | -$87 | -$5 | -$18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $13 | -$8 | -$5 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$18 | -$21 | -$35 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1 | $1 | $2 |
| Financing Cash Flow | $0 | -$6 | -$28 | -$38 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $31 | -$42 | -$5 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55 | $98 | $103 | $110 |
| End Cash | $31 | $55 | $98 | $103 |
| Free Cash Flow | $31 | $51 | $28 | $49 |